A study has shown that Roche's diabetic macular oedema (DME) therapy Vabysmo is effective in patients who identify as African American, Black, Hispanic and Latino, plugging a gap in the data for ...

Eylea HD can be administered at a maximum of every 16 weeks for AMD and DME and every 12 weeks for DR. A new dosing option would give Eylea HD a much-needed boost against Vabysmo, which can be ...

eye drug Vabysmo and allergy treatment Xolair. Quarterly group revenues came in at 15.44 billion Swiss francs ($18.64 billion), slightly above average market expectations of about 15.4 billion ...

Investors will look at commentary on blockbuster eye drug Vabysmo's sales performance, which could slow down in the U.S. due to potential Medicare funding issues affecting patients, UBS and ...

The plant, which will mark Roche’s second for branded medicines in the country, will mainly be used for domestic production of the eye med Vabysmo, which goes by the commercial moniker Luoshijia ...

FRANKFURT (Reuters) -Swiss drugmaker Roche said on Thursday its first-quarter sales rose a forecast-beating 7% driven by breast cancer drug Phesgo, eye drug Vabysmo and allergy treatment Xolair.